Anat Bar-Shira
Overview
Explore the profile of Anat Bar-Shira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldstein O, Shani S, Gana-Weisz M, Elkoshi N, Casey F, Sun Y, et al.
J Parkinsons Dis
. 2025 Feb;
:1877718X241310722.
PMID: 39973498
Background: While and variants are associated with Parkinson's disease (PD), most carriers will not develop the disease. Objective: To test if polygenic risk score (PRS) modifies disease risk and phenotypes...
2.
Shani S, Gana-Weisz M, Bar-Shira A, Thaler A, Gurevich T, Mirelman A, et al.
J Parkinsons Dis
. 2025 Feb;
14(8):1575-1583.
PMID: 39957192
Background: The adaptive immune response has a role in Parkinson's disease (PD). Patients with or mutations often exhibit distinct clinical characteristics. Objective: To evaluate the involvement of adaptive immune response...
3.
Droby A, Yoffe-Vasiliev A, Atias D, Fraser K, Mabrouk O, Omer N, et al.
NPJ Parkinsons Dis
. 2025 Jan;
11(1):7.
PMID: 39753572
Alpha-synuclein (αS) aggregation is a widely regarded hallmark of Parkinson's disease (PD) and can be detected through synuclein amplification assays (SAA). This study investigated the association between cerebrospinal fluid (CSF)...
4.
Shiner T, Kave G, Mirelman A, Regev K, Piura Y, Goldstein O, et al.
Mov Disord
. 2024 Aug;
39(12):2280-2285.
PMID: 39212252
Background: Glucocerebrosidase 1 (GBA1) mutations are associated with reduced survival in Parkinson's disease but their effect on survival in dementia with Lewy bodies (DLB) is unclear. Objective: To assess the...
5.
Barel D, Marom D, Ponger P, Kurolap A, Bar-Shira A, Kaplan-Ber I, et al.
J Neurol
. 2024 Apr;
271(7):4258-4266.
PMID: 38625400
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder. It is mostly sporadic, with the C9orf72 repeat expansion being the most common genetic cause. While the prevalence of C9orf72-ALS in...
6.
Shani S, Gana-Weisz M, Bar-Shira A, Thaler A, Gurevich T, Mirelman A, et al.
Genes (Basel)
. 2024 Jan;
15(1).
PMID: 38254936
: locus is associated with Parkinson's disease (PD), which is located within a large inversion region of high linkage disequilibrium (LD). We aimed to determine whether the H2-haplotype protective effect...
7.
Goldstein O, Gana-Weisz M, Banfi S, Nigro V, Bar-Shira A, Thaler A, et al.
Mol Genet Metab
. 2023 May;
139(2):107608.
PMID: 37201419
Objectives: VPS35 and VPS13 have been associated with Parkinson's disease (PD), and their shared phenotype in yeast when reduced in function is abnormal vacuolar transport. We aim to test if...
8.
Shani S, Goldstein O, Gana-Weisz M, Bar-Shira A, Thaler A, Gurevich T, et al.
Parkinsonism Relat Disord
. 2023 Apr;
111:105398.
PMID: 37116292
Introduction: Recent studies found an association between Parkinson's disease (PD) and alterations in the innate immune system. However, whether the involvement of this system in two of the known genetic...
9.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, et al.
Mov Disord
. 2022 Jan;
37(3):651-652.
PMID: 35064687
No abstract available.
10.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, et al.
Mov Disord
. 2021 Sep;
37(1):190-195.
PMID: 34550621
Background: Mutations in the GBA gene, which encodes the lysosomal enzyme glucocerebrosidase (GCase), are risk factors for Parkinson's disease (PD). Objective: To explore the association between GCase activity, PD phenotype,...